Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kiss, Bernhard
INCyst, NCT05726786: The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy ( Trial)	Recruiting	3	232	Europe	Immunonutrition	Centre Hospitalier Universitaire Vaudois, Insel Gruppe AG, University Hospital Bern, Hôpital Riviera-Chablais, Vaud-Valais	Bladder Cancer, Interstitial Cystitis, Painful Bladder Syndrome, Neurogenic Bladder, Hemorrhagic Cystitis, Endometriosis, Bladder Disease	08/26	10/26
MACOCUC-01, NCT05738161: Magrolimab in Combination With Cytotoxic Chemotherapy in Advanced Urothelial Carcinoma	Withdrawn	1	26	NA	Magrolimab, Hu-5F9-G4, Cisplatin, L01XA01 Cisplatin, Gemcitabine, L01BC05 Gemcitabine	Insel Gruppe AG, University Hospital Bern, University of Bern, Swiss National Science Foundation	Advanced Urothelial Carcinoma	02/24	02/24
Özdemir, Berna
MACOCUC-01, NCT05738161: Magrolimab in Combination With Cytotoxic Chemotherapy in Advanced Urothelial Carcinoma	Withdrawn	1	26	NA	Magrolimab, Hu-5F9-G4, Cisplatin, L01XA01 Cisplatin, Gemcitabine, L01BC05 Gemcitabine	Insel Gruppe AG, University Hospital Bern, University of Bern, Swiss National Science Foundation	Advanced Urothelial Carcinoma	02/24	02/24